featured
Quarterly Summary—Recent Developments in VHL-Related Research
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Wang J, Peng X, Chen C, et al. Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors. Front Genet. 2019;10:358.
- Minervini G, F Quaglia F, F Tabaro F, et al. Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred From a Large-Scale Analysis of Disease Mutations and Interactors. PLoS Comput Biol. 2019;15(4):e1006478.
- Buffet A, Ben Aim L, Leboulleux S, et al. Positive Impact of Genetic Testing on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma. J Clin Endocrinol Metab. 2019;104(4):1109-1118.
- Hong B, Zhang Z, Zhou J, et al. Distinctive Clinicopathological Features of Von Hippel-Lindau-Associated Hereditary Renal Cell Carcinoma: A Single-Institution Study. Oncol Lett. 2019;17(5):4600-4606.
- Flores SK, Cheng Z, Jasper AM, et al. A synonymous VHL variant in exon 2 confers susceptibility to familial pheochromocytoma and von Hippel-Lindau disease. J Clin Endocrinol Metab. 2019 Apr 4. doi: 10.1210/jc.2019-00235. [Epub ahead of print.]
- Shell J, Tirosh A, Millo C, et al. The Utility of 68Gallium-DOTATATE PET/CT in the Detection of von Hippel-Lindau Disease Associated Tumors. Eur J Radiol. 2019;112(112):130-135.